Ptc Therapeutics, Inc. financial data

Symbol
PTCT on Nasdaq
Industry
Pharmaceutical Preparations
Location
500 Warren Corporate Center Drive, Warren, NJ
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 218 % +48%
Quick Ratio 5.08 % -18.2%
Debt-to-equity -280 % +18%
Return On Assets -20 % +51.2%
Operating Margin -37.5 % +20%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 78.9M shares +2.83%
Common Stock, Shares, Outstanding 77.7M shares +2.64%
Entity Public Float 1.73B USD -25.6%
Common Stock, Value, Issued 77K USD +2.67%
Weighted Average Number of Shares Outstanding, Basic 76.8M shares +2.68%
Weighted Average Number of Shares Outstanding, Diluted 76.8M shares +2.68%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 807M USD -14%
Research and Development Expense 534M USD -19.8%
Operating Income (Loss) -303M USD +31.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -363M USD +47.8%
Income Tax Expense (Benefit) 176K USD -2189%
Net Income (Loss) Attributable to Parent -363M USD +42%
Earnings Per Share, Basic -4.73 USD/shares +43.5%
Earnings Per Share, Diluted -4.73 USD/shares +43.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 780M USD +31.3%
Marketable Securities, Current 360M USD +27.3%
Inventory, Net 23.2M USD -24.1%
Assets, Current 1.37B USD +12.1%
Property, Plant and Equipment, Net 61M USD -30%
Operating Lease, Right-of-Use Asset 56.7M USD -38.3%
Intangible Assets, Net (Excluding Goodwill) 119M USD -68.7%
Goodwill 82.3M USD 0%
Assets 1.71B USD -10.1%
Accounts Payable, Current 17.3M USD +186%
Employee-related Liabilities, Current 61.6M USD -1.71%
Contract with Customer, Liability, Current 5.51M USD +587%
Liabilities, Current 581M USD -3.67%
Deferred Income Tax Liabilities, Net 55.9M USD +7.67%
Operating Lease, Liability, Noncurrent 74.9M USD -23.2%
Other Liabilities, Noncurrent 21.4M USD +15096%
Liabilities 2.8B USD +3.27%
Accumulated Other Comprehensive Income (Loss), Net of Tax -25.9M USD -1914%
Retained Earnings (Accumulated Deficit) -3.65B USD -11.1%
Stockholders' Equity Attributable to Parent -1.1B USD -34.1%
Liabilities and Equity 1.71B USD -10.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 70.8M USD
Net Cash Provided by (Used in) Financing Activities 540K USD -86.8%
Net Cash Provided by (Used in) Investing Activities -115M USD -297%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 77.7M shares +2.64%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -45.7M USD +26.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 795M USD +30.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3.67M USD -71.7%
Deferred Tax Assets, Valuation Allowance 858M USD +2.85%
Deferred Tax Assets, Gross 869M USD +3.33%
Operating Lease, Liability 85.3M USD -22.9%
Payments to Acquire Property, Plant, and Equipment 9.59M USD -6.64%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -388M USD +38.7%
Lessee, Operating Lease, Liability, to be Paid 128M USD -49.5%
Property, Plant and Equipment, Gross 94.3M USD -31.8%
Operating Lease, Liability, Current 10.4M USD -20.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 16.4M USD -19.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 16M USD -12.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure -11.5%
Deferred Income Tax Expense (Benefit) -1K USD +75%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 42.4M USD -70.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 13.9M USD -30.5%
Unrecognized Tax Benefits 108M USD +7840%
Lessee, Operating Lease, Liability, to be Paid, Year Four 7.62M USD -57.5%
Operating Lease, Payments 3.95M USD +3.6%
Additional Paid in Capital 2.57B USD +4.39%
Amortization of Intangible Assets 60.7M USD -72.7%
Depreciation, Depletion and Amortization 55.4M USD +29.4%
Deferred Tax Assets, Net of Valuation Allowance 11.7M USD +56.9%
Share-based Payment Arrangement, Expense 74.6M USD -26.6%